Investors Capital Advisory Services’s VanEck Biotech ETF BBH Stock Holding History

Investors Capital Advisory Services’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,545	Closed	-$323K	–	702
2015 Q4	$323K	Sell	2,545 -540	-18%	-$66.2K	0.06%	413
2015 Q3	$352K	Buy	3,085 +260	+9%	+$34.4K	0.07%	385
2015 Q2	$380K	Buy	2,825 +200	+8%	+$26.6K	0.07%	396
2015 Q1	$340K	Buy	2,625 +50	+2%	+$6.28K	0.06%	421
2014 Q4	$297K	Buy	+2,575	New	+$290K	0.06%	444

Other funds holding BBH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LFM

Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Investors Capital Advisory Services's BBH Position: Q1 2016 in Review

Investors Capital Advisory Services sold out of VanEck Biotech ETF (BBH) in Q1 2016, closing a stake of 2,545 shares — an estimated $323K sold.

Investors Capital Advisory Services first reported a position in BBH in Q4 2014 and held it in 5 quarters. The position peaked at $380K in Q2 2015. 71 funds tracked by Wall St. Rank hold BBH as of Q1 2016.

Investors Capital Advisory Services reported no remaining VanEck Biotech ETF position as of Q1 2016 after selling out during the quarter.
Investors Capital Advisory Services sold 2,545 VanEck Biotech ETF shares in Q1 2016, an estimated $323K.
Investors Capital Advisory Services first reported a position in VanEck Biotech ETF in Q4 2014 and held it in 5 quarters.
Investors Capital Advisory Services's VanEck Biotech ETF position peaked at $380K in Q2 2015.
71 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2016.

Based on Investors Capital Advisory Services's 13F filing for Q1 2016, filed 9 May 2016.